Who are we ?

Thanks to the experience of our founder, Gilles Bos, and that of our collaborators acquired at Corneal, Allergan, Anteis, Aptissen, etc. we are confident that we have all the tools to make SyrHA's vision a reality.
Our vision

Our Vision 

Medical devices based on hyaluronic acid are constantly being improved. We strive to bring our technical expertise and make your hyaluronic-acid-based medical devices  safer and more effective.

Our ambition

We seek to capitalize on our expertise in hyaluronic acid and our  raw materials of high quality and purity.  So when your formulas are combined with our proprietary manufacturing technology, we add value to the development and implementation of your products. 

In collaboration with its partners, SyrHA wishes to  contribute to the marketing of innovative products for uses as  diverse as aesthetic, ophthalmological and musculoskeletal.

Our value

Our values

We pride ourselves on our teamwork, transparency, dedication to Swiss quality standards, open-mindedness, efficiency, entrepreneurial spirit and strong customer service.

Our story

  • 1992

    OVD d’origine animale
    Développement Viscorneal
  • 2000

    Développement de juvederm
  • 2005

    Développement d’esthélis
  • 2011

    Belotero certifié FDA
  • 2013

    Développement de synolis
  • 2018

    SyrHatech démarre ses activités de CDMO
  • 2019

    Développement de INTEXHYA
  • 2020

    Syrha GMP / ISO 13485 en tant que CDMO

Explore our environment

  • Company

    SyrHATech goes to CPHI Barcelona – from 10/24 to 10/26

    The CPHI (Convention on Pharmaceutical Ingredients) is the reference event for the pharmaceutical industry. Itinerant…

    CPHI Barcelona 2023
  • Company

    Inauguration of Syrhatech’s new premises in Geneva

    The Syrhatech team was delighted to share a convivial moment on its terrace on the…

    Inauguration of Syrhatech's new premises in Geneva
  • Company

    Development of a specific syringe for wrinkle filler

    Our customer contacts us to validate the design of a syringe made of plastic by…

  • Company

    Development of an innovative gel with very high concentration

    Our client contacts us to industrialize a new manufacturing technique, compatible with the objectives of…

  • Company

    Technology transfer

    Our team relies on its many years of experience and past successes, to prepare and…

    Syrhatech - technology transfer
  • Company

    Development of a cross-linked HA formulation containing peptides

    At the request of our customer, this cross-linked HA product incorporates peptides for various therapeutic…

    Syrhatech - Value added technology
  • Company

    Development of a cross-linked hydrogel similar to an existing product

    Reverse engineering and formulation of cross-linked HA for specific (non-aesthetic) applications, and development of steam…

  • Company

    Formulation of a new polymer

    Technology transfer and development of a manufacturing process for a polysaccharide other than hyaluronic acid…

    Syrhatech - Who are we ?